Targeting the OXE receptor as a potential novel therapy for asthma is a research paper published in Biochemical Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: MOP-6254
Canadian Institutes of Health Research
Grant: PP2-133388
NHLBI NIH HHS
Grant: R01 HL081873
American Asthma Foundation
Grant: 12-0049
National Institutes of Health
Grant: 5R01HL081873-14
Biochemical Pathways of 12-HETE and 12-KETE Metabolism
Canadian Institutes of Health Research
Grant: unidentified
unidentified
AmorChem
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals